Hepatitis treatment depends entirely on which type you have. Hepatitis A clears on its own with rest and fluids. Hepatitis B may require long-term antiviral medication. Hepatitis C is now curable in over 95% of cases with a short course of oral pills. Here’s what treatment looks like for each type and what to expect during recovery.
Hepatitis A: No Medication Needed
There are no specific medications for hepatitis A. Your body fights off the virus on its own, and the infection never becomes chronic. Treatment focuses on managing symptoms with rest, a balanced diet, and plenty of fluids. Most people recover within two months, though 10% to 15% of cases involve relapsing symptoms that can stretch out to six months. People with severe cases may need to be hospitalized for monitoring, but this is uncommon.
Hepatitis B: Long-Term Antiviral Therapy
Acute hepatitis B, like hepatitis A, usually resolves on its own in adults. The concern is chronic hepatitis B, where the virus persists in your body and can slowly damage the liver over years. Not everyone with chronic hepatitis B needs treatment right away. Your doctor will monitor your viral levels and liver function to decide when to start.
When treatment is needed, the standard approach is a daily antiviral pill. Three medications are currently recommended as first-line options: entecavir, tenofovir DF, and tenofovir alafenamide. These drugs work by blocking the virus from copying itself inside liver cells, which lowers the amount of virus in your blood and reduces ongoing liver damage. The catch is that most people need to take these medications indefinitely. Stopping too early can cause the virus to flare back up. Treatment doesn’t typically cure hepatitis B, but it controls it effectively enough to prevent serious complications like cirrhosis and liver cancer.
Hepatitis C: A Curable Infection
Hepatitis C treatment has transformed dramatically. A class of medications called direct-acting antivirals can cure the infection in more than 95% of people. Treatment involves taking pills daily for 8 to 12 weeks, with no injections required. Side effects are generally mild compared to the older interferon-based treatments that were standard a decade ago.
“Cure” in this context means the virus is completely undetectable in your blood after treatment ends, a result known as sustained virologic response. Once you’ve achieved that, the infection is gone for good, though any liver damage that occurred before treatment won’t reverse on its own. That’s why earlier treatment leads to better long-term outcomes. The CDC now recommends that all adults be screened for hepatitis B at least once in their lifetime, and similar universal screening efforts exist for hepatitis C, precisely because many people carry these viruses without knowing it.
Hepatitis D: The Most Difficult to Treat
Hepatitis D only infects people who already have hepatitis B, making it a co-infection that accelerates liver damage. Treatment options are more limited than for other types. Interferon injections, given weekly for about 48 weeks, have been the standard approach, though response rates are modest.
A newer medication called bulevirtide, which blocks the virus from entering liver cells, has shown promise when combined with interferon. In a clinical trial published in the New England Journal of Medicine, 46% of patients receiving the combination had no detectable virus 48 weeks after finishing treatment, compared to 25% with interferon alone and just 12% with bulevirtide alone. Treatment for hepatitis D remains longer and less predictable than for hepatitis C, but the combination approach represents a meaningful step forward.
Hepatitis E: Usually Self-Limiting
Most hepatitis E infections resolve without treatment, similar to hepatitis A. The exception is people with weakened immune systems, particularly organ transplant recipients, who can develop chronic hepatitis E. For these patients, the first step is reducing the dose of their immune-suppressing medications to let the body fight the virus. If that doesn’t work, a three-month course of an antiviral called ribavirin is typically prescribed. Dosing is adjusted based on kidney function, since the drug can cause side effects like anemia.
Autoimmune Hepatitis
Not all hepatitis is caused by a virus. In autoimmune hepatitis, the immune system mistakenly attacks liver cells, causing chronic inflammation. Treatment focuses on calming that immune response. The standard first-line approach combines a corticosteroid (usually prednisolone) with azathioprine, a drug that suppresses immune activity. Most people respond well to this combination, though treatment often needs to continue for years. In patients without advanced scarring, a corticosteroid called budesonide may be used instead, as it tends to cause fewer body-wide side effects.
Alcohol and Diet During Recovery
Regardless of which type of hepatitis you have, alcohol is one of the most important things to eliminate. If you have active liver inflammation or cirrhosis, you should stop drinking completely. Alcohol forces the liver to work harder at a time when it’s already struggling to heal, and continued use dramatically worsens outcomes. For alcohol-associated liver disease specifically, quitting is the single most effective treatment available.
Dietary changes also play a role in recovery. A balanced diet that supports liver function typically means eating enough protein to help with tissue repair, limiting salt to reduce fluid retention, and staying well hydrated. Some people with advanced liver disease need specific dietary adjustments, including vitamin supplementation, that their care team will outline based on their situation.
When Liver Transplant Becomes Necessary
For any form of hepatitis that progresses to severe, irreversible liver damage, a transplant may be the only remaining option. Transplant evaluation is generally considered appropriate when cirrhosis becomes decompensated, meaning complications like fluid buildup in the abdomen, bleeding from swollen veins in the digestive tract, or confusion caused by toxins the liver can no longer filter. A scoring system called MELD, which estimates the severity of liver disease, helps determine transplant priority. A score of 15 or higher typically qualifies a patient for the transplant waiting list, though many doctors refer patients for evaluation once the score reaches 10 so the process is already underway if things worsen.
The good news is that effective antiviral treatments, particularly for hepatitis C, have significantly reduced the number of people who reach this stage. Early detection and treatment remain the most powerful tools for avoiding severe liver damage in the first place.